SHH · 688265.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Shanghai Model Organisms Center, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.98% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
BEHIND THE RESULTS
Shanghai Model Organisms Center, Inc.’s next earnings report is currently expected on Oct 30, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Shanghai Model Organisms Center, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Shanghai Model Organisms Center, Inc. (SMOC) is a prominent Chinese enterprise dedicated to the research and development of genetically engineered animal models. The company offers a broad spectrum of specialized rodent models, encompassing disease-specific, humanized, immunodeficient, tool, and fluorescent reporter strains of both mice and rats. Furthermore, SMOC produces custom cellular products, including fluorescently labeled, primary, and humanized cell lines. Beyond its core product offerings, SMOC delivers a comprehensive suite of support services. These include personalized model generation, animal husbandry and breeding programs, in-depth phenotypic analysis, and critical drug screening and evaluation services for preclinical research. Established in 2000, SMOC maintains its primary operations and corporate headquarters in Shanghai, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥27.45-CN¥0.46 (-1.65%)
Zhejiang Wecome Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.75% below the high.
CN¥16.09-CN¥0.64 (-3.83%)
Shanghai ZJ Bio-Tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
CN¥11.48-CN¥0.26 (-2.21%)
Qingdao Vland Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.64% below the high.
CN¥7.54-CN¥0.19 (-2.46%)
Baolingbao Biology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.5% below the high.
CN¥10.26-CN¥0.12 (-1.16%)
Guanhao Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.0% below the high.
CN¥13.58-CN¥0.04 (-0.29%)
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.88% below the high.
CN¥13.85-CN¥0.19 (-1.35%)
Yantai Zhenghai Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.71% below the high.
CN¥5.69-CN¥0.23 (-3.89%)
Shenzhen Bioeasy Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 50.52% below the high.
